XYL
58
6
VMC
60
-3
CFG
40
8
HRL
35
-3
ADBE
56
5
LUV
33
-3
VLO
45
3
BF.B
50
-7
CHRW
50
2
WMB
56
-4
SBUX
44
3
PPG
66
2
A
46
3
PCAR
53
5
GS
69
4
BWA
49
7
PG
48
-3
HST
57
5
BRK.B
45
3
SEE
41
4
XYL
58
6
VMC
60
-3
CFG
40
8
HRL
35
-3
ADBE
56
5
LUV
33
-3
VLO
45
3
BF.B
50
-7
CHRW
50
2
WMB
56
-4
SBUX
44
3
PPG
66
2
A
46
3
PCAR
53
5
GS
69
4
BWA
49
7
PG
48
-3
HST
57
5
BRK.B
45
3
SEE
41
4
Financhill
Back

Citius Pharmaceuticals Quote, Financials, Valuation and Earnings

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17

CTXR
Citius Pharmaceuticals

Last Price:
0.56
Seasonality Move:
-3.95%

7 Day Trial

ALL ACCESS PASS

$ 7

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Citius Pharmaceuticals Price Quote

$0.56
+0.01 (+2.17%)
(Updated: September 20, 2024 at 2:30 PM ET)

Citius Pharmaceuticals Key Stats

Sell
17
Citius Pharmaceuticals (CTXR) is a Sell
Day range:
$0.52 - $0.58
52-week range:
$0.48 - $1.07
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.16%
Volume:
1.8M
Avg. volume:
1.4M
1-year change:
-23.4%
Market cap:
$99.1M
Revenue:
$0
EPS:
$-0.24

How Much Does Citius Pharmaceuticals Make?

Data Unavailable

Is Citius Pharmaceuticals Growing As A Company?

Data Unavailable

Citius Pharmaceuticals Stock Price Performance

What Is Citius Pharmaceuticals 52-Week High & Low?

Citius Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Citius Pharmaceuticals?

Is Citius Pharmaceuticals Cash Flow Positive?

  • What Is CTXR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$29.1M
  • What Is Citius Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Citius Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Citius Pharmaceuticals Return On Invested Capital

Data Unavailable

Citius Pharmaceuticals Earnings Date & Stock Price

Citius Pharmaceuticals Competitors

Citius Pharmaceuticals Dividend Yield

Citius Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -33.33%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 4.67
Upside from Last Price: 751.43%

Major Shareholders

  • How many CTXR shares are owned by institutional investors?
    40.9M CTXR shares are owned by institutional investors
  • How many CTXR shares are owned by insiders?
    12.3M CTXR shares are owned by insiders